You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
順騰國際控股(00932.HK)擬與美國Biotech設合資共同開發抗衰老保健產品
格隆匯 09-02 22:52

格隆匯9月2日丨順騰國際控股(00932.HK)公告,於2020年9月2日,公司與Regenerative Biotech訂立諒解備忘錄,據此訂約方同意真誠磋商以就合作項目訂立正式協議。訂約方同意於香港註冊成立合資公司,其將由公司及Regenerative Biotech等額擁有。

合資公司的股本總額,連同各訂約方注入的金額、時間及投資方式須受限於進一步磋談及載於正式協議。根據諒解備忘錄,訂約方同意透過合資公司利用人工智能及機器學習藥物發現技術共同開發研究及生產抗衰老保健產品的平台。公司擬協助合資公司擴大公司及Regenerative Biotech的銷售渠道及宣傳彼等的保健產品。訂約方的權利及責任詳情將載於正式協議。

位於美國的Regenerative Biotech為一間於英屬處女羣島註冊成立的有限公司。該公司為一家高端企業,主要從事抗衰老及保健產品的研發。Regenerative Biotech利用人工智能及機器學習藥物發現技術,研發抗衰老及保健產品。

公司預期透過結合其於零售及電子商務業務的經驗,加上Regenerative Biotech研發及零售抗衰老藥物及保健產品的專業背景及知識而獲益。合資公司將發展及建立專注於抗衰老保健產品的人工智能研發中心,並設立科研項目。憑藉Regenerative Biotech的頂尖人工智能機器學習及最新計算化學技術,集團預期,合資公司將有助擴大及促進集團現有生產及零售保健產品業務的發展。

預期合作項目亦將擴大公司的銷售渠道,因為其與公司主要從事抗衰老保健及美容補品配方、銷售及分銷的業務性質類似,因此預期能增加集團的盈利能力及為集團帶來長遠價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account